BackgroundInitially described as a relatively benign condition, recent studies report graft loss in up to 50% of the patients with post-transplant IgA nephropathy. There is no evidence for the best therapeutic approach, and prognostic factors remain to be elucidated.Material/MethodsSingle center retrospective analysis of patients >12 years old, with clinically relevant post-transplant IgA nephropathy (proteinuria ≥1.0 g/g and/or graft dysfunction) and ≥6 months follow-up after diagnosis (n=47).ResultsLiving donor transplants represented 85% of cases. Dysmorphic hematuria (100%), blood pressure elevation (95.7%), renal dysfunction (70.2%) and subnephrotic proteinuria (60.6%) predominated at presentation. Using the Oxford Classification, mesangial proliferation was the main histological lesion (91%). Treatment consisted mostly of blockade of the renin angiotensin system (89.4%) and modification of immunosuppression (85.1%), mainly by increasing oral steroids dose (83%), with venous pulse therapy in 63.8% of cases. Partial and complete remission occurred in 48.9% and 17% of cases, respectively. One patient died (sepsis) and 15 patients (31.9%) lost their grafts due to nephropathy. The percentage of decrease in glomerular filtration rate at diagnosis was independently associated with partial remission (HR 0.97, 95% CI 0.94–0.99, p=0.01) and graft loss (HR 1.13, 95% CI 1.06–1.20, p<0.001). Deceased donor (HR 28.04, 95% CI 4.41–178.39, p<0.001) and donor age (HR 1.1, 95% CI 1.04–1.16, p=0.001) were also risk factors for graft loss.ConclusionsDespite treatment, most patients with post-transplant IgA nephropathy in this cohort study presented unfavorable outcomes, and graft dysfunction at diagnosis appeared to be the main prognostic marker.
Background. Renal replacement therapy (RRT) is a public health problem worldwide. Kidney transplantation (KT) is the best treatment for elderly patients’ longevity and quality of life. Objectives. The primary endpoint was to compare elderly versus younger KT recipients by analyzing the risk covariables involved in worsening renal function, proteinuria, graft loss, and death one year after KT. The secondary endpoint was to create a robot based on logistic regression capable of predicting the likelihood that elderly recipients will develop worse renal function one year after KT. Method. Unicentric retrospective analysis of a cohort was performed with individuals aged ≥60 and <60 years old. We analysed medical records of KT recipients from January to December 2017, with a follow-up time of one year after KT. We used multivariable logistic regression to estimate odds ratios for elderly vs younger recipients, controlled for demographic, clinical, laboratory, data pre- and post-KT, and death. Results. 18 elderly and 100 younger KT recipients were included. Pretransplant immune variables were similar between two groups. No significant differences (P>0.05) between groups were observed after KT on laboratory data means and for the prevalences of diabetes mellitus, hypertension, acute rejection, cytomegalovirus, polyomavirus, and urinary infections. One year after KT, the creatinine clearance was higher (P = 0.006) in youngers (70.9 ± 25.2 mL/min/1.73 m2) versus elderlies (53.3 ± 21.1 mL/min/1.73 m2). There was no difference in death outcome comparison. Multivariable analysis among covariables predisposing chronic kidney disease epidemiology collaboration (CKD-EPI) equation <60 mL/min/1.73 m2 presented a statistical significance for age ≥60 years (P = 0.01) and reduction in serum haemoglobin (P = 0.03). The model presented goodness-fit in the evaluation of artificial intelligence metrics (precision: 90%; sensitivity: 71%; and F1 score: 0.79). Conclusion. Renal function in elderly KT recipients was lower than in younger KT recipients. However, patients aged ≥60 years maintained enough renal function to remain off dialysis. Moreover, a learning machine application built a robot (Elderly KTbot) to predict in the elderly populations the likelihood of worse renal function one year after KT.
This was a case-control study to identify prognostic indicators of bacterial meningitis in a reference hospital in Pernambuco/Brazil. The data were collected from charts of 294 patients with bacterial meningitis between January 2000 and December 2004. Variables were grouped in biological, clinical, laboratory and etiologic agent/treatment. Variables selected in each step were grouped and adjusted for age. Two models were created: one containing clinical variables (clinical model) and other containing laboratory variables (laboratory model). In the clinical model the variables associated with death due to bacterial meningitis were dyspnea (p=0.006), evidence of shock (p=0.051), evidence of altered mental state (p=0.000), absence of headache (p=0.008), absence of vomiting (p=0.052), and age ≥40 years old (p=0.013). In the laboratory model, the variables associated with death due to bacterial meningitis were positive blood cultures (p=0.073) and thrombocytopenia (p=0.019). Identification of prognostic indicators soon after admission may allow early specific measures, like admission of patients with higher risk of death to Intensive Care Units.
A despeito dos enormes avanços tecnológicos quanto ao diagnóstico, compreensão da sua patogênese e seu tratamento, a meningite bacteriana (MB) ainda permanece como importante doença de distribuição mundial, sendo também endêmica no Brasil ABSTRACTThere is controversy regarding indications for cerebrospinal fluid control tests on patients who have clinically recovered from bacterial meningitis, as a cure criterion. Some authors advocate discharge after confirmation of clinical and cerebrospinal fluid normalization, while others maintain that cerebrospinal fluid analysis is not justified in all cases. This case series with group comparisons investigated changes seen in cerebrospinal fluid control tests and evaluated the importance of this for the discharge decision. Out of 297 patients studied, the cerebrospinal fluid control test did not change the discharge intention in 89.9% of the cases (healed cerebrospinal fluid), while in 10.1%, the discharge was suspended (non-healed cerebrospinal fluid). Of these, the antibiotic scheme was changed in 30%. Among the variables that might predict the presence of non-healed cerebrospinal fluid on admission, cerebrospinal fluid protein levels higher than 100mg/dl (p = 0.04) and glycorrhachia lower than or equal to 20 mg/dl (p = 0.03) were associated with a 2.5-times greater chance. These may be useful as criteria for indicating cerebrospinal fluid control tests before discharge.Key-words: Bacterial meningitis. Cerebrospinal fluid. Cerebrospinal fluid protein levels. Glycorrhachia.por pneumococos resistentes à penicilina e cefalosporina, que receberam terapia com dexametasona e vancomicina 13. Contudo, há dúvidas sobre a indicação do exame do liquor de controle em todos os pacientes, após o tempo estimado de antibioticoterapia e estando já recuperados clinicamente da MB, como critério de alta hospitalar. Alguns autores defendem que a alta hospitalar só deve ser dada após a normalização do quadro clínico e liquórico 1 6 11 . Outros consideram que o critério para alta é fundamentalmente clínico e o exame de controle, como rotina, não é justificável em todos os pacientes 7 8 9 13 . Atualmente, no Hospital Correia
Introduction: Kidney transplant (KT) has the highest survival rate amongst kidney replacement therapies (KRT). Objective: Analyze the incidence density of all-cause mortality in chronic kidney disease transplant-recipients and to identify covariables associated with higher risk of death. Methodology: Cohort study using medical records of 605 KT patients with seven years follow-up (2011-2018). Records with insufficient data or from patients with incomplete treatment were excluded. The variables analyzed were demographic, clinical and laboratory data, duration of KRT, type of donor, immunological compatibility, panel-reactive HLA-antibody, infections, and use of hypothermic perfusion machine (HPPM). Hazard ratio (HR) and incidence density of all-cause deaths were estimated. Results: 15 of 553 KT-recipients died during the follow-up. The survival in the first year post-KT was 98.0% and in the fifth year was 93.2%. The incidence density of deaths is 10/1,000 person-years. Variables pre- and post-KT related with higher death risk were allograft pyelonephritis ≥6-months and delayed graft function >4 weeks. Survival among KT-recipients with loss >5 mL/min/1.73m2/year in the estimated glomerular filtration rate (eGFR) were lower than the others (88% vs. 97%). Covariates associated with mortality post-transplant included pre-KT obesity, HPPM, allograft pyelonephritis, and new-onset diabetes after transplantation. Conclusion: The mortality post-KT is low in these population. Cox's modelling demonstrated that the decline in eGFR >5 mL/min/1.73m2/year, allograft pyelonephritis ≥6-months, pre-KT obesity, fasting blood glucose ≥126 mg/dL presented worst probability of survival. Rapid decline in eGFR reduces substantially the survival probability in these population.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.